Trump’s Iran Speech Disappoints Markets

Key takeaways

President Trump claims the Iran conflict is nearing an end, addressing military progress but leaving many questions unresolved.
Concerns surrounding U.S. withdrawal from NATO and the implications for global defense strategy are now at the forefront.
Eli Lilly's new weight loss pill, Foundayo, aims to capture the market with ease of use, despite competition.
The nursing profession is gaining recognition as a stable path to the middle class, amid shifting job landscapes.

Summary

Trump’s Address on the Iran Conflict

In a recent address to the nation, President Trump asserted that the war in Iran is close to conclusion, despite acknowledging forthcoming major military operations. His remarks sought to allay fears of a prolonged U.S. military involvement, mentioning that the U.S. has been engaged in the conflict for just 32 days. Highlighting the support from Gulf nations, he indicated that those countries must take the lead in securing their oil passages while reinforcing that the U.S. does not rely on imported oil from the region.

Concerns Over Oil and Military Strategy

The potential closure of the Strait of Hormuz by Iranian forces raises concerns for Gulf nations regarding oil exports. While Trump praised the military progress, he left questions about U.S. involvement in reopening the Strait unanswered. Global markets reacted with caution, highlighted by drops in stock futures and rising energy prices amid concerns over ongoing military tensions.

NATO and Global Alliances in Question

Trump hinted at the possibility of withdrawing from NATO amidst criticism regarding member countries' support for the war in Iran. However, legal complexities surrounding such a move could make it difficult. Analysts discussed the implications should the U.S. pull out and its impact on defense collaborations with European allies.

Eli Lilly’s Weight Loss Pill Approval

Eli Lilly received regulatory approval for its GLP-1 weight-loss pill, Foundayo, which will compete against Novo Nordisk’s Wigovie. While Foundayo showed modest results compared to its competitor, its ease of use is highlighted by the company as a significant advantage. Analysts predict that it could yield substantial global sales for Eli Lilly in the coming years.

The Evolving Path to the Middle Class

As traditional pathways to the middle class, such as factory and office jobs, face challenges from automation and AI, nursing has emerged as a reliable alternative. The demand for healthcare professionals is expected to grow significantly due to an aging population and increased healthcare needs. Registered nurses can earn nearly double the median income of all occupations in the U.S., reflecting the profession's importance in today's economy.

Show notes

A.M. Edition for April 2. In a prime-time address to the nation roughly a month into the Iran war, President Trump claims the conflict is nearing an end, even as he says major attacks are still to come. WSJ national security correspondent Shelby Holliday breaks down what Trump said—and didn’t say—about how Washington plans to resolve the crisis in the Strait of Hormuz. Plus, the weight-loss pill battle begins after Eli Lilly’s Foundayo wins U.S. regulatory approval. And reporter Jeanne Whalen explains how nursing could be the new ticket to the elusive American middle class. Luke Vargas hosts.

Sign up for the WSJ’s free What’s News newsletter.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.